Chronic Obstructive Pulmonary Disease Linked to Higher Risk of Death from Cardiovascular Disease
Data from Japan has been presented, highlighting a strong correlation between chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD). Researchers from Jikei University and other institutions have uncovered a shared risk factor for both conditions, with the prevalence of each disease increasing with age. The study emphasizes the need for clinicians to address cardiopulmonary risk, particularly in patients with co-existing COPD and CVD, as the risk of death is significantly higher in these individuals. The study also stresses the importance of early COPD diagnosis and timely treatment to prevent exacerbations and reduce mortality rates.
Key Takeaways:
- Research from Jikei University found a strong correlation between COPD and CVD, with both conditions sharing several risk factors.
- The prevalence of both diseases increases with age, making early diagnosis and treatment crucial.
- Patients with co-existing COPD and CVD have a significantly higher risk of death due to cardiopulmonary complications.
- Lowering cardiopulmonary risk is essential to reduce mortality rates, and inhaled therapies can prevent COPD exacerbations.
- There is a need for a comprehensive approach to address cardiopulmonary risk, involving both respiratory and cardiology societies.
- The study highlights the importance of urgent action to address cardiopulmonary risk and reduce COPD and CVD deaths.
Statistics:
- The prevalence of CVD and COPD increases with age, with a higher risk of co-existing conditions in older patients.
- In patients with co-existing COPD and CVD, the risk of death is significantly higher due to cardiopulmonary complications.
- Inhaled therapies can prevent COPD exacerbations and may reduce mortality rates.
- The study emphasizes the need for urgent action to address cardiopulmonary risk and reduce COPD and CVD deaths.
Sources:
*Circulation Journal, "Cardiopulmonary Risk In Chronic Obstructive Pulmonary Disease - a Perspective for Reducing Mortality -"
*Japanese Circulation Soc, 6TH Floor, Uchikanda Central Building, 1-18-13 Uchikanda, Chiyoda-Ku, Toyko, 101-0047, Japan
*Michihiro Yoshimura, Jikei University, School of Medicine, Tokyo, Japan
*Additional authors: Shigeo Muro, Koichiro Kuwahara, Hisatoshi Sugiura, Koichi Fukunaga, Ryoko Sorimachi, Munehiro Seki, and Toyoaki Murohara